iecrowd pitch deck

24
Investor Presentation July 2014 ieCrowd Innovation Economy Corporation

Upload: banqofferings

Post on 05-Dec-2014

289 views

Category:

Business


4 download

DESCRIPTION

Innovation Economy Corporation, a Delaware corporation dba Innovation Economy Crowd (the "Company" or “ieCrowd”), in a private placement memorandum dated July 14, 2014, has commenced a private offering (the “Offering”) of its securities in the amount of $2,000,000. The Company proposes to sell, through a Regulation D, Rule 506(c) offering, a total of $5,000,000 of the Company's Unsecured Convertible Promissory Notes (the “Notes”). The Notes bear interest a rate of eight percent (8%) per annum and are convertible into common stock at $0.34 per share. The Notes are being offered to an unlimited number of Accredited Investors. A minimum purchase of one (1) Note for $25,000 is required from any potential investor.

TRANSCRIPT

Page 1: IeCrowd Pitch Deck

Investor PresentationJuly 2014

ieCrowdInnovation Economy Corporation

Page 2: IeCrowd Pitch Deck

2

DisclaimerStatements & Management

This presentation contains forward-looking statements and management may make additional forward-looking statements in response to your questions. Such written and oral disclosures are made pursuant to the Safe Harbor provision of the Private Securities Litigation Reform Act of 1995.

Although we believe our expectations expressed in such forward looking statements are reasonable, we cannot assure you that they will be realized. Investors are cautioned that such forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from the anticipated results, and therefore we refer you to a more detailed discussion of the risks and uncertainties in the Company’s private placement memorandum.

The forward-looking statements contained in this presentation are made only as of today, and Innovation Economy Corporation. and TriPoint Global Equities, LLC are under no obligation to revise or update these forward-looking statements.

Simultaneous with this Offering, the Company is conducting a separate offering pursuant to Regulation S of the Act (the “Regulation S Offering”). Through the Regulation S Offering, the Company is offering up to $2,500,000 convertible notes and may close on a minimum purchase of up to $100,000. Following receipt of the minimum purchase in either the Regulation S Offering or this Offering, the Company may continue either, both or none of such offerings.

Page 3: IeCrowd Pitch Deck

3

INNOVATION ECONOMY CORPORATION

SummaryWho is ieCrowd?

Innovation Economy Corporation dba ieCrowd

Based in Riverside, CA Founded in 2010 Over $7m equity raised to date

ieCrowd transforms breakthrough life and health discoveries into global solutions

Bridges the innovation gap between promising IP developed at top research institutions and global marketing companies in search of new products

• Target Cost: $1-$3m per discovery• Time frame: 18-36 months to commercialize• Target: 4-6 new discoveries per year

3 innovation platforms in development

• Kite: Repellents and lures for mosquitoes and other blood-seeking insects

• Nuuma: Air quality monitoring and gas detection using nanotechnology sensors

• Ascent: Adaptive regulation of oxygen tanks for COPD, and congestive heart failure patients.

Proposed Transaction

Industry: Life Sciences

Type of Offering Convertible Note

Capital Raise $5.0m

Terms

Conversion: $0.34/share Forced Conversion: 80% of IPO Share Price Coupon: 8%

Recent Equity Valuation

$45m

CapitalizationBasic: 140m shares

Fully Diluted: 185mExpected Closing August 15, 2014

OwnershipMgmt & employees: 58%

Outside investors: 42%Auditor Marcum LLP

Placement Agent TriPoint Global EquitiesPlacement Agent Counsel

Hunter Taubman Weiss

Page 4: IeCrowd Pitch Deck

4

The CrowdThe Crowd expands ieCrowd’s access to expertise, innovations, networks and resources. The Crowd adds

significant value in key areas of ieCrowd’s business.

Capital

Accredited Investors Angels Institutions Funds Foundations Medical Professionals Fund

Development Partners

Vendors Collaborators Foundations Gov. Agencies Universities

Health and Medical Global Solutions

Distribution Retail Direct

Collaborators Verticals

Life and Health Breakthrough Discoveries University Partners Labs Gov. Agencies Innovators Challenges/Competitions

Consolidated Business Infrastructure

ieCrowd Solutions

Page 5: IeCrowd Pitch Deck

5

Discover

ProcessDiscovery to Market

Develop

ieCrowd mobilizes a business infrastructure that optimizes the rapid development of these disruptive technologies into solutions or platforms in a target period of 18-36 months

Launch

ieCrowd’s solutions platform is designed to launch products to a global market via a network of market partners in health and medical industries

ieCrowd looks out for innovations everywhere, and then marries them with experienced entrepreneurs with the know-how to build strong, smart and purpose driven companies.

- MeiMei Fox

ieCrowd obtains from top-tier universities the exclusive rights for innovative life and health technologies that can be commercialized rapidly and have an accessible global market greater than $1B

Page 6: IeCrowd Pitch Deck

6

DiscoverieCrowd Finds the Right Innovations

Licenses in Place

Discover Grant Money Intellectual Property Do good & do well

• Clear path to revenue generation within 18-36 months (targeted)

• Leverages ieCrowd’s expertise and infrastructure

• Positive social impact attracts stakeholders and partners

• Patent Issued/Pending IP

• Orphaned at a top research institution

• Demonstrated proof of concept or prototype

• Prior financial support through research grants

• Value is waiting to be unlocked

• Potential for follow-on grants in-house

• Global accessible market > $1B

• Disruptive approach to improve existing tech

• Platform technology leading to a suite of products

ieCrowd sources life and health focused discoveries by partnering with technology transfer offices at top-tier research institutions.

Innovation Sources

Page 7: IeCrowd Pitch Deck

7

Develop

ieCrowd’s business infrastructure supports the efficient development of discoveries into market-ready product solutions.

ieCrowd assigns a team of experienced ieCrowd entrepreneurs and subject matter experts to lead commercialization.

Each discovery benefits from ieCrowd’s technology and product development process and business operations platform to move through commercialization efficiently and cost effectively.

Targeted Capital Allocation: $1.5 - 3m per Discovery

• Accounting • Legal • Procurement/Engineering • Marketing

• IT• Facilities & Safety • Human Resources• Development Partners

Support Services

Innovation Company 1Subject Matter Expert

Innovation Company 2Subject Matter Expert

Future Innovation CompaniesSubject Matter Experts

...

Page 8: IeCrowd Pitch Deck

8

Launch Growing Network of Partners will Enable Products to Launch Globally

ieCrowd is designed to work with global industry market partners to manufacture and distribute future market-ready solutions.

Market partners share the risks and costs and will enable ieCrowd to achieve scale by focusing efforts on commercialization.

Licensing Partners• Product platforms available for exclusive global licenses, specific field of use and/or regional licenses.• Revenue: royalties and license fees

Distribution Partner• Finished products and/or technologies available for distribution to specific verticals or regional markets.• Original Equipment Manufacturer (OEM)• Revenue: Purchase of products directly from ieCrowd

Direct-to Consumer/Retail• Finished products designed, developed, manufactured, and sold directly by ieCrowd• Revenue: Retail sales

Page 9: IeCrowd Pitch Deck

9

Company Structure

Innovations are placed into a newly formed, majority owned and operated ieCrowd subsidiary focused on commercializing that innovation.

ieCrowd’s proprietary screening model has already yielded 3 disruptive technologies/solutions in development, each with significant future global potential.

• Nano Engineered Applications, Inc.

• Wearable gas nano-sensors

• Olfactor Laboratories, Inc.

• Insect repellents and lures

• Breathing Technologies, Inc.

• Adaptive oxygen delivery device

TM

®

Page 10: IeCrowd Pitch Deck

10

Product Name Kite Nuuma AscentInnovation Company Olfactor Laboratories, Inc. Nano Engineered Applications, Inc. Breathing Technologies, Inc.Description Developing technologies

capable of making humans virtually invisible to mosquitoes and other host-seeking insects plus lures for surveillance and traps.

Developing wearable, intelligent, Smart-phone enabled products capable of detecting airborne molecules ranging from toxic, disease-causing gases to VOCs to the parts per billion

Developing breakthrough mobile oxygen delivery systems and smart automated adaptive controls for COPD and congestive heart failure patients

Acquisition February, 2010 April, 2010 December, 2013Product Stage Launch Development DiscoveryTime to Revenue Within 12 months Within 12-16 months 12-16 monthsResearch Partner UC Riverside UC Riverside UC San DiegoPatents 4 Pending (3 developed in

house, 1 exclusive license) 2 Issued, 4 Pending; exclusive license

1 Pending, exclusive license

Grant Funding $3m in total Grants-NIH- Bill & Melinda Gates Foundation

$3m in Grants-NIH

$100K+-UC Proof of Concept Program

Sample Design

CURRENTLY IN R & D

InnovationsA Growing Portfolio

®TM

Page 11: IeCrowd Pitch Deck

11

Olfactor Laboratories, Inc. - OLI ieCrowd Subsidiary developing Kite Product Platform

OLI’s new approach develops products based on chemicals that manipulate the activity of the host seeking insect’s carbon dioxide (CO2) detection pathway• Utilizes its laboratory facility in Riverside, CA to monitor insect behavior and test compounds in a range

of simulated environments• Female mosquitoes are attracted to expelled CO2 because they need blood to feed and lay eggs OLI is developing products that will emphasize safety and efficacy

Host seeking insects• Mosquitoes, Sand flies, Tsetse flies, bed bugs • Nuisance of bites• Vectors of diseases: Malaria, Dengue fever, West Nile virus • Mosquito-borne diseases impact over half the world’s population

Market Size • $3B USA pest control1

• $527m USA insect repellent1

End uses• Repellents: personal and spatial• Lures for home and yard

1. U.S. retail home and

garden pest control market,

includes controls, households,

repellents, and rodenticides.

2013, Spectrum Brands;

makers of Cutter & Repel

The Kite logo is a registered trademark of Olfactor Laboratories, Inc.

Page 12: IeCrowd Pitch Deck

12

Kite PatchIntroduction

artistic rendering

Small patch applied to clothing for personal Mosquito control Being developed to release active ingredients from the patch• Designed to create a zone around the individual• Blocks the mosquito’s ability to detect CO2 and thus limits their ability to efficiently

find the individual wearing the patch• Active ingredients are non-DEET fragrance and flavor compounds addressing

concerns about the safety of DEET Lure study with Walter Reed Army Institute of Research in Peru and Thailand conducted April and May 2014

Preparing for international testing in Uganda Signed license agreement with first market partner in South Korea, Malaysia, and Indonesia

Next steps • Complete product development and field testing• Sign additional market partners• Spatial Repellents: room, home, yard• Professional product development: lures and traps• Introduce repellent and lure for Bed Bugs• Apply for EPA regulatory approval

Page 13: IeCrowd Pitch Deck

13

Kite PatchCredibility & Traction

Indiegogo• $557,254 raised from 11,254 funders over 45 days• #1 most popular campaign for four weeks of the six-week campaign• Top funded Indiegogo campaign in “small business” category

Global media • Coverage from over 400 publications • $30m in estimated earned global media

Page 14: IeCrowd Pitch Deck

14

Nano Engineered Applications, Inc. - NEA ieCrowd Subsidiary developing Nuuma Product Platform

NEA is developing a suite of products that use an “Electronic Nose” based on sensors made from carbon nanotubes• Low power sensors detect airborne molecules • Gases, and volatile organic compounds (VOCs) down to the parts per billion (PPB)

Market size• US indoor air quality equipment: $3.7B1

• Global gas sensors: $1.7B2

• Global wearable products: $1.6B3

• Wearable fitness devices: $330m in US4

End uses• Wearable, intelligent, highly portable sensors

• Air quality monitoring• Indoor and outdoor; consumer, commercial, and military

NEA Sensor

1. BCC Research, 2012

2. Grandview Research

3. BIS, 2013

4. NPD Research

artistic rendering

Page 15: IeCrowd Pitch Deck

15

NuumaIntroduction

Wearable smartphone enabled nano-sensor under development • Detects unhealthy disease-causing gases and VOCs around the user• Forms a distributed network of air quality monitors• Monitors hyper-local air quality just like weather or traffic

Signed license agreement with first market partners• South Korea• Malaysia • Indonesia

Next Steps• Complete product development for application in consumer health

and wellness space• Launch first solution and increase market awareness• Sign additional market partners

Air map artistic rendering

Page 16: IeCrowd Pitch Deck

16

Breathing Technologies, Inc. - BTIieCrowd Subsidiary developing Ascent Product Platform

Developing a new class of products based on intelligent adaptive oxygen controls• On-demand, measured oxygen driven by lightweight microprocessors• First major changes to oxygen therapy technology

Prototype in use by the inventor • COPD patient with 30-40% lung capacity regularly uses prototype while doing

physical activity, ranch work, golfing

Market size• COPD is the third leading cause of death in America1

• 14.8m diagnosed COPD patients and another 12m un-diagnosed2

• Oxygen therapy in the US: $440m3

End Uses:• Oxygen therapy for patients with COPD• Oxygen therapy for patients with Congestive Heart Failure

1. Center for Disease Control and Prevention2. NIH, 20123. Millennium Research Group, 2010

Page 17: IeCrowd Pitch Deck

17

AscentIntroduction

New COPD-targeted oxygen therapy device for patients using supplemental oxygen in tanks• Delivers more oxygen when you need it the most• Monitors blood oxygen level• Collects valuable medical data• Lower cost and higher efficiencies than oxygen conservers• Designed to enable full mobility, in and outdoors

Signed license agreement with first market partner

Clinical trial is underway at the Pulmonary Rehabilitation Clinic at UCSD Medical Center • Funded by public proof of concept grant

Next steps• Complete successful trial and publish findings• Complete product development• File for FDA approval• Sign additional market partners

Page 18: IeCrowd Pitch Deck

18

Solutionsfrom ieCrowd

Within 12 months

Within 24 months

Within 28 months

TBD

TBD

Within 12 to 16 months

Breakthrough Life & Health Solutions

Health &Wellness

Disease Prevention

Disease Management

Time to Revenue

Kite Solutions – Breakthrough technology in the fight against mosquito borne diseases

Kite Consumer Products - Breakthrough disease prevention for everyone

Kite Public Health Products - New weapons in war against mosquito-borne diseases

Kite Active Ingredients Licensing - Repellents, lures

Nuuma Solutions - Solutions for health & wellness and disease prevention

Nuuma Life (Consumer) - “Know air, know your health”—disease prevention devices

Ascent Solutions - Next generation of smart oxygen devices

Ascent I - Smart, adaptive and networked oxygen devices

Ascent II - Emergency oxygen devices (sea, air, land)

Page 19: IeCrowd Pitch Deck

19

ProjectionsRevenue & Income

(USD Millions) 2015E 2016E 2017E 2018E

REVENUE 6.8 30.3 65.6 158.7

GROSS PROFIT 3.3 15.1 32.7 78.7

OPERATING EXPENSES (11.3) (17.0) (22.7) (45.6)

NET INCOME (8.0) (1.9) 10.0 33.1

Page 20: IeCrowd Pitch Deck

20

TeamLeadership

ieCrowd’s executive team is comprised of experienced entrepreneurs and senior leaders, collectively responsible for multiple IPOs, M&As, exits, multiple high-growth startups, and generating stakeholder value.

Amro AlbannaCEO

Dale HutchinsPresident

David KayattaCapital

Al CervantesCFO

Michelle BrownScience

Grey FrandsenSolutions

Larry EasonMarketing

Molly SchmidLife and Health

Sundip DoshiTechnology

Steve AbbottDiscovery

Rowena Albanna Operations

Page 21: IeCrowd Pitch Deck

21

Leadership and Entrepreneurship• Experience building successful global brands and launching products• Experience with high-growth first-to-market technologies • Deep experience working with technology transfer• Operational leadership of $100m+ companies

Past Exits• Timely Technology Corp. - internet transaction security – Acquired• Digital Angel Corporation - GPS/Wireless – Went public• University of California, Riverside (UCR) Research Park - Real Estate - Acquired• Qmotions/Actiga – Video game controller – Went public

Life and Health Technology• Leadership in commercializing breakthrough scientific discoveries and product

adoption• Experience with regulated and unregulated life and health products, public health,

disease, and wellness markets• Expertise to create solutions at the interface of data and personal health

Past Projects• Microcide Pharmaceuticals- Antibiotic Drugs – IPO• Genencor Inc – Industrial Biotech –IPO• Affinium Pharmaceuticals – Antibiotics – Big Pharma Partnerships

TeamBackground

Page 22: IeCrowd Pitch Deck

22

Use of Proceeds

Item Amount

Project development and commercialization $2,200,000

General, administrative and marketing 1,287,500

Legal, accounting & consultants 500,000

Working Capital 612,500

Placement Agent Fee 400,000

Total Proceeds $5,000,000

Project Development• Increase investments to fast track Kite, Nuuma and Ascent

to market• Advance research, development and regulatory approval

process• Acquire additional life and health discoveries

Marketing• Broaden brand awareness• Expand access to world-class partners• Raise profile to attract world-class talent & gain awareness• Expand relationships with universities and tech transfer

agents

Page 23: IeCrowd Pitch Deck

23

Clearly defined commercialization model • Costly, risk-laden early-stage research is left to innovators on campuses and completed

prior to discovery acquisition by ieCrowd• Secures the rights to an innovation and places into rapid development• Strict acquisition criteria and deals that are structured for oversight • Go to market with global partners

Scalable investment method• $1.5m – 3m over 18-36 months• Results in globally salable technology

• Company targets 10x ROI on the commercialization of each innovation

Build a community of partners invested in success• Doing good and doing well• Involve the crowd in early market validation and product launches

Efficient allocators of capital• $7m+ in capital raised to date through ieCrowd common equity• Approximately $6m in non-dilutive public and private grants directly into research

(prior to ieCrowd licensing the discovery) • Approximately $1m in non-dilutive public grants directly and indirectly into ieCrowd’s

projects post-licensing.

Investment Highlights

Page 24: IeCrowd Pitch Deck

24

ContactTriPoint Global Equities, LLC

Mark Elenowitz, CEO

130 West 42 St, 10th Fl

New York, NY, 10036

P: 917-512-0822

F: 212-202-6380

E: [email protected]

TriPoint Global Equities, LLC

For full offering details and documentation please go to Banq.co